SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-004583
Filing Date
2019-04-01
Accepted
2019-04-01 17:07:48
Documents
86
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2206689
2 ex21-1.htm EX-21.1 6559
3 ex23-1.htm EX-23.1 5052
4 ex23-2.htm EX-23.2 11480
5 ex31-1.htm EX-31.1 18443
6 ex31-2.htm EX-31.2 18627
7 ex32-1.htm EX-32.1 8336
8 ex32-2.htm EX-32.2 8309
  Complete submission text file 0001493152-19-004583.txt   7410939

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE heb-20181231.xml EX-101.INS 1170553
10 XBRL SCHEMA FILE heb-20181231.xsd EX-101.SCH 80128
11 XBRL CALCULATION FILE heb-20181231_cal.xml EX-101.CAL 73712
12 XBRL DEFINITION FILE heb-20181231_def.xml EX-101.DEF 286086
13 XBRL LABEL FILE heb-20181231_lab.xml EX-101.LAB 527349
14 XBRL PRESENTATION FILE heb-20181231_pre.xml EX-101.PRE 388432
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-27072 | Film No.: 19721670
SIC: 2836 Biological Products, (No Diagnostic Substances)